GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 52 filers reported holding GALERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,878 | -94.5% | 313,226 | -1.4% | 0.00% | – |
| Q2 2023 | $990,752 | +97.2% | 317,549 | +61.8% | 0.00% | – |
| Q1 2023 | $502,374 | +193120.8% | 196,240 | +12.2% | 0.00% | – |
| Q4 2022 | $260 | -99.9% | 174,924 | +5.6% | 0.00% | – |
| Q3 2022 | $288,000 | +179.6% | 165,651 | +108.7% | 0.00% | – |
| Q2 2022 | $103,000 | -45.2% | 79,364 | 0.0% | 0.00% | – |
| Q1 2022 | $188,000 | -45.3% | 79,364 | +5.6% | 0.00% | – |
| Q4 2021 | $344,000 | -43.6% | 75,143 | -0.3% | 0.00% | – |
| Q3 2021 | $610,000 | -12.9% | 75,350 | +5.7% | 0.00% | – |
| Q2 2021 | $700,000 | -31.7% | 71,256 | -38.7% | 0.00% | – |
| Q1 2021 | $1,025,000 | -11.9% | 116,266 | +2.2% | 0.00% | – |
| Q4 2020 | $1,163,000 | +26.7% | 113,708 | +11.9% | 0.00% | – |
| Q3 2020 | $918,000 | +36.6% | 101,598 | +7.9% | 0.00% | – |
| Q2 2020 | $672,000 | +43.9% | 94,185 | +91.4% | 0.00% | – |
| Q1 2020 | $467,000 | -52.4% | 49,217 | -34.2% | 0.00% | – |
| Q4 2019 | $982,000 | – | 74,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $2,815,000 | 0.83% |
| Sofinnova Investments, Inc. | 3,083,712 | $14,154,000 | 0.83% |
| Novo Holdings A/S | 2,459,021 | $11,287,000 | 0.53% |
| ACUTA CAPITAL PARTNERS, LLC | 262,500 | $1,205,000 | 0.51% |
| Tekla Capital Management LLC | 898,374 | $4,124,000 | 0.13% |
| Aristides Capital LLC | 20,000 | $92,000 | 0.04% |
| XTX Topco Ltd | 13,499 | $62,000 | 0.04% |
| Blackstone Inc. | 1,678,984 | $7,707,000 | 0.02% |
| Taylor Wealth Management Partners | 11,635 | $53,000 | 0.02% |
| Belvedere Trading LLC | 96,486 | $255,000 | 0.01% |